Framing the future of diagnostics
Roche is committed to finding innovative solutions for serious, currently unsolved medical challenges that will make a genuine difference to the lives of patients worldwide.
Introducing the cobas m 511*
Using Bloodhound® technology, the cobas m 511 combines a digital morphology analyzer, cell counter and classifier into one streamlined instrument preparing, staining and analyzing microscopy blood smears.
*in development Read More
Central nervous system diseases
Drugs designed to act on the brain often come to grief at the blood-brain barrier. The effective purpose of the barrier, found in all vertebrates, is to protect the brain from harmful Read Article
New ways forward in virology
Viral disease represents an insidious and serious health risk. Viruses are often not detected early enough. This allows them to spread uncontrollably. Since viruses can quickly mutate Read Article
Targeted correction of metabolic disorders
Metabolic disorders can produce the most varied conditions, such as diabetes, arteriosclerosis or hypertension. In their effort to develop drugs against such widespread diseases Read Article
Research & Development at our German sites
Roche in Penzberg is situated on the foothills of the Alps near Munich, Germany. The campus is one of the largest Biotechnology-Centers in Europe, employing more than 5000 highly Read Article